Hladan-2MIU (Colistimethate Sodium Vials) 2MIU

Hladan-2MIU contains colistimethate sodium, an antibiotic used to treat bacterial infections. This injectable vial delivers 2MIU per unit for systemic use. Store at ambient temperature and use as directed by a healthcare professional. Not for self-administration without supervision.

Strength

2MIU

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Wanbury

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Colistimethate sodium is primarily used to treat serious bacterial infections, including those caused by certain gram-negative bacteria. It is often prescribed when other antibiotics are ineffective or unsuitable. This medication works by disrupting bacterial cell membranes, aiding in infection clearance. It may be used for hospital-acquired or ventilator-associated pneumonia.

Side Effects

Common effects include mild pain or irritation at the injection site. Some users may experience mild gastrointestinal discomfort or dizziness. These effects are generally temporary and resolve without intervention. Rarely, more pronounced reactions like rash or itching may occur.

Precautions & Warnings

Keep this medication out of reach of children and pets. Store at room temperature, away from moisture and direct light. Do not use if the vial is damaged or the solution appears cloudy. Always follow the handling instructions provided by your healthcare provider or pharmacist.

Avoid Interactions

Colistimethate sodium may interact with other medications, including certain muscle relaxants and diuretics. Alcohol use should be avoided during treatment due to potential increased side effects. Inform your healthcare provider about all medications and supplements you are taking before starting this treatment.

References

Frequently Asked Questions

Hladan-2MIU is used to treat serious bacterial infections caused by gram-negative bacteria, often when other antibiotics are not effective.

This medication is administered as an injection by a healthcare professional, typically in a clinical setting.

Hladan-2MIU is available for purchase through licensed pharmacies and medical suppliers with a valid prescription.

Common side effects may include mild pain at the injection site, gastrointestinal discomfort, or dizziness.

Safety during pregnancy should be discussed with a healthcare provider, as risks and benefits must be considered.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.